Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,221 to 1,240 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC). | Mod Pathol | 2020 | 32457407 | PubTator, text mining | PubMed |
| Human pluripotent stem cell-derived cardiac stromal cells and their applications in regenerative medicine. | Stem Cell Res | 2020 | 32446219 | PubTator, text mining | PubMed |
| Toripalimab-Induced Dermatomyositis in a Patient with Metastatic Melanoma. | Dermatol Ther (Heidelb) | 2020 | 32445174 | PubTator, text mining | PubMed |
| Identification of a Triple Drug Combination That Is Synergistically Cytotoxic for Triple-Negative Breast Cancer Cells Using a Novel Combination Discovery Approach. | SLAS Discov | 2020 | 32441190 | PubTator, text mining | PubMed |
| Aberrant expression of CPSF1 promotes head and neck squamous cell carcinoma via regulating alternative splicing. | PLoS One | 2020 | 32437477 | PubTator, text mining | PubMed |
| High polymerase ε expression associated with increased CD8+T cells improves survival in patients with non-small cell lung cancer. | PLoS One | 2020 | 32433714 | PubTator, text mining | PubMed |
| Functional Interplay Between Collagen Network and Cell Behavior Within Tumor Microenvironment in Colorectal Cancer. | Front Oncol | 2020 | 32426274 | PubTator, text mining | PubMed |
| Modeling atrial fibrosis in vitro-Generation and characterization of a novel human atrial fibroblast cell line. | FEBS Open Bio | 2020 | 32421922 | PubTator, text mining | PubMed |
| DDR2, a discoidin domain receptor, is a marker of periosteal osteoblast and osteoblast progenitors. | J Bone Miner Metab | 2020 | 32415375 | PubTator, text mining | PubMed |
| Coordinated regulation of cell survival and cell cycle pathways by DDR2-dependent SRF transcription factor in cardiac fibroblasts. | Am J Physiol Heart Circ Physiol | 2020 | 32412792 | PubTator, text mining | PubMed |
| Impact of Extracellular Matrix Components to Renal Cell Carcinoma Behavior. | Front Oncol | 2020 | 32411604 | PubTator, text mining | PubMed |
| Diverse LEF/TCF Expression in Human Colorectal Cancer Correlates with Altered Wnt-Regulated Transcriptome in a Meta-Analysis of Patient Biopsies. | Genes (Basel) | 2020 | 32403323 | PubTator, text mining | PubMed |
| Cryptic collagen elements as signaling hubs in the regulation of tumor growth and metastasis. | J Cell Physiol | 2020 | 32400053 | PubTator, text mining | PubMed |
| Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors. | BMC Cancer | 2020 | 32397977 | PubTator, text mining | PubMed |
| PD-L1 expression in malignant pleural effusion samples and its correlation with oncogene mutations in non-small cell lung cancer. | J Thorac Dis | 2020 | 32395276 | PubTator, text mining | PubMed |
| Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis. | Proc Natl Acad Sci U S A | 2020 | 32393644 | PubTator, text mining | PubMed |
| Predictive value of tumor genetic alteration profiling for chemotherapy and EGFR-TKI treatment in advanced NSCLC. | Oncol Lett | 2020 | 32382334 | PubTator, text mining | PubMed |
| Usefulness of Two Independent DNA and RNA Tissue-Based Multiplex Assays for the Routine Care of Advanced NSCLC Patients. | Cancers (Basel) | 2020 | 32365867 | PubTator, text mining | PubMed |
Blockade of Discoidin Domain Receptor 2 as a Strategy for Reducing Inflammation and Joint Destruction in Rheumatoid Arthritis Via Altered Interleukin-15 and Dkk-1 Signaling in Fibroblast-Like Synoviocytes. | Arthritis Rheumatol | 2020 | 32362074 | PubTator, text mining | PubMed |
| Matrix-transmitted paratensile signaling enables myofibroblast-fibroblast cross talk in fibrosis expansion. | Proc Natl Acad Sci U S A | 2020 | 32358190 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=62